Avitas Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1,716
| Closed | -$208K | – | 209 |
|
2023
Q2 | $208K | Sell |
1,716
-32
| -2% | -$3.89K | 0.04% | 195 |
|
2023
Q1 | $268K | Sell |
1,748
-58
| -3% | -$8.91K | 0.05% | 187 |
|
2022
Q4 | $324K | Buy |
1,806
+2
| +0.1% | +$359 | 0.07% | 167 |
|
2022
Q3 | $213K | Sell |
1,804
-638
| -26% | -$75.3K | 0.05% | 177 |
|
2022
Q2 | $349K | Sell |
2,442
-786
| -24% | -$112K | 0.08% | 161 |
|
2022
Q1 | $556K | Sell |
3,228
-866
| -21% | -$149K | 0.1% | 153 |
|
2021
Q4 | $1.04M | Buy |
4,094
+151
| +4% | +$38.4K | 0.17% | 124 |
|
2021
Q3 | $1.52M | Sell |
3,943
-1,600
| -29% | -$616K | 0.28% | 114 |
|
2021
Q2 | $1.3M | Sell |
5,543
-2,299
| -29% | -$540K | 0.23% | 124 |
|
2021
Q1 | $1.03M | Sell |
7,842
-8,247
| -51% | -$1.08M | 0.2% | 136 |
|
2020
Q4 | $1.68M | Sell |
16,089
-826
| -5% | -$86.3K | 0.34% | 116 |
|
2020
Q3 | $1.2M | Buy |
16,915
+4,478
| +36% | +$317K | 0.33% | 105 |
|
2020
Q2 | $799K | Buy |
12,437
+12
| +0.1% | +$771 | 0.27% | 111 |
|
2020
Q1 | $372K | Buy |
+12,425
| New | +$372K | 0.17% | 110 |
|